a genomic assay may predict long-term prognosis in premenopausal patients with hr early-stage bc
Published 1 year ago • 8 plays • Length 6:32Download video MP4
Download video MP3
Similar videos
-
2:34
genomic assays impact treatment decisions in patients with er breast cancer
-
2:47
genomic assays impact treatment decisions in patients with er breast cancer
-
18:45
agendia: the new era of genomic testing in early stage breast cancer.
-
2:20
dr. brufsky on choosing when to do a multiparameter genomic assay
-
1:01:02
genomic profiling of breast cancer: a multidisciplinary approach in early stage breast cancer...
-
14:37
genomic testing in breast cancer: what you must know
-
1:03:17
when to consider multi-gene testing in early-stage and metastatic breast cancer
-
28:11
2021 mdons | the nurses role in early stage breast cancer | a focus on genomic assays
-
2:21
choosing when to do a multiparameter genomic assay
-
1:37
dr. meisel on optimizing genomic assays in early-stage hr-positive, her2-negative breast cancer
-
14:30
new data on role of gene assays in breast cancer treatment - medpage today
-
0:59
using genomic assays for clinical decision making in early breast cancer: 2022 esmo florida
-
1:40
dr. simon on genomic assays for patients with breast cancer
-
1:30
utilizing genomic assays for decision making in early stage breast cancer
-
0:24
all mammogram results to include assessment of breast density
-
1:34
precision oncology: rajen mody, md on genetic sequencing for childhood cancer
-
1:22
dr. bobbie j. rimel on genetic testing in ovarian cancer
-
1:54
magenta genetic test for ovarian cancer
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer